Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02175745
What this trial is testing

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Who this might be right for
Adult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem Glioma+54 more
Erik Mittra 2
Testing effectiveness (Phase 2)Study completedNCT00600054
What this trial is testing

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

Who this might be right for
Recurrent Diffuse Pontine Gliomas
YM BioSciences 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03180502
What this trial is testing

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+5 more
NRG Oncology 120
Early research (Phase 1)Study completedNCT00005602
What this trial is testing

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Children's Oncology Group 13
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053880
What this trial is testing

Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Accendatech USA Inc. 48
Early research (Phase 1)Ended earlyNCT00895960
What this trial is testing

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

Who this might be right for
GlioblastomaCNS DiseaseBrain Diseases
M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT03251989
What this trial is testing

Rare CNS Tumors Outcomes &Risk

Who this might be right for
High Grade MeningiomaEpendymomaMedulloblastoma+2 more
National Cancer Institute (NCI) 326
Testing effectiveness (Phase 2)Study completedNCT02661282
What this trial is testing

Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

Who this might be right for
Cytomegalovirus PositiveGlioblastomaGliosarcoma+3 more
M.D. Anderson Cancer Center 65
Early research (Phase 1)Study completedNCT00472017
What this trial is testing

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 35
Testing effectiveness (Phase 2)UnknownNCT00180791
What this trial is testing

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Who this might be right for
MedulloblastomaBrain TumorsNeuroectodermal Tumors, Primitive
Gustave Roussy, Cancer Campus, Grand Paris 71
Large-scale testing (Phase 3)Study completedNCT02879682
What this trial is testing

NTMS for Motor Mapping of Rolandic Lesions

Who this might be right for
GliomaBrain Metastases
Technical University of Munich 330
Testing effectiveness (Phase 2)WithdrawnNCT04482933
What this trial is testing

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Who this might be right for
NeoplasmsHigh Grade GliomaGlioblastoma Multiforme+5 more
Pediatric Brain Tumor Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT03510208
What this trial is testing

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Who this might be right for
Malignant Brain NeoplasmMalignant Glioma
Stanford University 46
Testing effectiveness (Phase 2)Study completedNCT00003176
What this trial is testing

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 82
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Early research (Phase 1)Study completedNCT01654497
What this trial is testing

Dexanabinol in Patients With Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari, M.D., Ph.D. 26
Early research (Phase 1)Looking for participantsNCT05106296
What this trial is testing

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Who this might be right for
EpendymomaMedulloblastomaGlioblastoma+1 more
Theodore S. Johnson 37
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Early research (Phase 1)Study completedNCT00006025
What this trial is testing

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page